Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Epidemiological Characteristics of blaNDM-1 in Enterobacteriaceae and the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex in China from 2011 to 2012

  • Weimei Ou,

    Affiliation The Institute of Clinical Pharmacology, Peking University First Hospital, Peking University, Beijing, 100191, P.R. China

  • Lanqing Cui,

    Affiliation The Institute of Clinical Pharmacology, Peking University First Hospital, Peking University, Beijing, 100191, P.R. China

  • Yun Li,

    Affiliation The Institute of Clinical Pharmacology, Peking University First Hospital, Peking University, Beijing, 100191, P.R. China

  • Bo Zheng,

    Affiliation The Institute of Clinical Pharmacology, Peking University First Hospital, Peking University, Beijing, 100191, P.R. China

  • Yuan Lv

    lyzx5857@sina.com

    Affiliation The Institute of Clinical Pharmacology, Peking University First Hospital, Peking University, Beijing, 100191, P.R. China

Abstract

Objectives

The study aimed to investigate the prevalence and epidemiological characteristics of blaNDM-1 (encoding New Delhi metallo-β-lactamase 1) in Enterobacteriaceae and the Acinetobacter calcoaceticus-Acinetobacter baumannii complex (ABC) in China from July 2011 to June 2012.

Methods

PCR was used to screen for the presence of blaNDM-1 in all organisms studied. For blaNDM-1-positive strains, 16S rRNA analysis and Analytical Profile Index (API) strips were used to identify the bacterial genus and species. The ABCs were reconfirmed by PCR detection of blaOXA-51-like. Antibiotic susceptibilities of the bacteria were assessed by determining minimum inhibitory concentration (MIC) of them using two-fold agar dilution test, as recommended by the Clinical and Laboratory Standards Institute (CLSI). Molecular typing was performed using pulsed-field gel electrophoresis (PFGE). S1 nuclease-pulsed-field gel electrophoresis (S1-PFGE) and Southern blot hybridization were conducted to ascertain the gene location of blaNDM-1. Conjugation experiments were conducted to determine the transmission of blaNDM-1-positive strains.

Results

Among 2,170 Enterobacteriaceae and 600 ABCs, seven Enterobacteriaceae strains and two A. calcoaceticus isolates from five different cities carried the blaNDM-1 gene. The seven Enterobacteriaceae strains comprised four Klebsiella pneumoniae, one Enterobacter cloacae, one Enterobacter aerogen and one Citrobacter freundii. All seven were non-susceptible to imipenem, meropenem or ertapenem. Two A. calcoaceticus species were resistant to imipenem and meropenem. Three K. pneumoniae showed the same PFGE profiles. The blaNDM-1 genes of eight strains were localized on plasmids, while one was chromosomal.

Conclusions

Compared with previous reports, the numbers and species containing the blaNDM-1 in Enterobacteriaceae have significantly increased in China. Most of them are able to disseminate the gene, which is cause for concern. Consecutive surveillance should be implemented and should also focus on the dissemination of blaNDM-1 among gram-negative clinical isolates.

Introduction

Carbapenems are the mainstream treatment for antibiotic-resistant bacterial infections, especially infections triggered by multi-drug resistant gram-negative bacteria [1]. Therefore, the presence of carbapenemase, which can hydrolyze carbapenems, in clinical gram-negative organisms is an important threat to public health [2]. More worryingly, New Delhi metallo-β-lactamase 1 (NDM-1; encoded by blaNDM-1), a new type of carbapenemase, can hydrolyze almost all known β-lactam antimicrobials (except aztreonam), including the last resort carbapenems [3]. Bacteria carrying blaNDM-1 are thus referred to as “superbugs” by the media. This article focused on the problem of carbapenem resistance mediated by NDM-1.

NDM-1, a new type of Ambler class B metallo-β-lactamases (MBLs), was first reported in K. pneumoniae and Escherichia coli derived from a Swedish patient of Indian origin who was admitted to hospital in New Delhi, India in 2009 [4]. Since then, blaNDM-1-positive bacteria have been disseminated worldwide, including all seven continents, except Antarctica. The Indian subcontinent and China are the major reservoirs. Balkan states, such as Serbia, Montenegro and Bosnia-Herzegovina may be considered as a ‘secondary’ reservoir area, while the Middle East (Morocco, Algeria, Libya, Egypt, Iraq, Kuwait, Oman, Lebanon and Afghanistan), Southeast Asia (South Korea, Indonesia, Vietnam and Thailand) and parts of Europe (France, Italy) may be additional reservoir areas [5]. The blaNDM-1 gene has been detected in K. pneumoniae, E. coli, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter aerogenes, Proteus spp., Citrobacter freundii, Morganella morganii, Providencia spp., Acinetobacter spp. and Raoultella ornithinolytica [6][24]. It is typically carried by plasmids, but can be chromosomal [25]. Plasmids carrying blaNDM-1 are mostly transferable and coexist with many other resistance determinants [12], [14], [18], further complicating the treatment of NDM-1-producing bacteria infections.

This study retrospectively surveyed the nationwide epidemiology of blaNDM-1 in Enterobacteriaceae and ABCs strains derived from the Ministry of Health National Antimicrobial Resistance Surveillance Net (Mohnarin) program in China, from July 1, 2011 to June 30, 2012. The Mohnarin program was established by the Ministry of Health in 2004 to obtain a more complete picture of bacterial resistance in China to provide scientific data for clinical antibiotic applications. Based on the surveillance hospital definition standards, including geographic distribution, clinical microbiological capability and hospital willingness, 18 hospitals located in 18 different cities around China were selected as the monitoring sites of Mohnarin. The Institute of Clinical Pharmacology, Peking University First Hospital, was assigned as the central laboratory for the Mohnarin organization and was, therefore, in charge of the surveillance, both coordinating the program and carrying out the minimal inhibitory concentration (MIC) analyses.

Materials and Methods

Bacterial strains

All strains in the study were collected from the Mohnarin program. The specimens were all passively collected from patients’ clinical samples in the program, in other words, the strains were collected from regular clinical examination without damaging the patients’ interest, and the patients’ personal privacies were protected. In total, 2170 Enterobacteriaceae and 600 ABCs were collected from 18 tertiary hospitals representing 18 different cities in China participating in the the Mohnarin program, from July 1, 2011 to June 30, 2012. The specimens were isolated from patients’ blood, urine, secretion, sputum, feces, drainage, throat swab, cerebrospinal fluid and others, mostly collected from intensive care units (ICU, 17.8%), non-intensive care units (NICU, 81.6%) (Some strains were not specified as being from ICU or NICU). The patients’ characteristics were male (61.6%), female (37.3%), the elderly (34.7%), adults (55.1%) and children (9.2%). Only the first strain of duplicated isolates from the same patient was collected. Further information about the patients, such as the underlying disease and possible antimicrobial pretreatment, were, unfortunately, not available. 338 Enterobacteriaceae and 395 ABCs that were not susceptible to carbepenem were selected from the 2170 Enterobacteriaceae and 600 ABCs in the program to detect the blaNDM-1 gene. Concurrent quality control strains used for antimicrobial susceptibility tests were E. coli ATCC25922, E. coli ATCC35218 and Pseudomonas aeruginosa ATCC27853. Salmonella serotype Braenderup strain H9812 was used as the marker for pulsed field gel electrophoresis (PFGE).

PCR amplification

The DNA extraction was performed from fresh culture using the boiling technique. The primers used were based on primers published by the Chinese Center for Disease Control and Prevention (CDC), F: TCG CAT AAA ACG CCT CTG; R: GAA ACT GTC GCA CCT CAT [26]. The amplicons were sequenced and compared with the published sequence in GenBank database using multiple sequence alignment.

Species identification

The bacterial genera of the blaNDM-1-positive organisms were identified by PCR amplification of 16S rRNA, using the universal primers 27F-AGAGTTTGATCCTGGCTCAG and 1492R-GGCTACCTTGTTACGACTT [27]. The PCR products were sequenced and compared with the published sequence in GenBank by multiple sequence alignment. To determine the species, a Kligler Iron Agar assay was carried out first to detect whether the bacteria were fermentative or not. The bacteria were further distinguished using Analytical Profile Index (API) 20E or 20NE tests (bioMe'rieux, Craponne, France) to further identify the bacterial species. The non-fermentative bacteria were identified using API 20NE, while the Enterobacteriaceae were identified using API 20E. The ABCs were distinguished by PCR detection of blaOXA-51-like, which is intrinsic to A. baumannii, using primers previously reported as F: TAA TGC TTT GAT CGG CCT TG; R: TGG ATT GCA CTT CAT CTT GG [28].

Antimicrobial susceptibility

The MICs of the blaNDM-1-positive isolates and transconjugants were determined using the agar dilution method, according to the recommendations given in document M100-S23 of the Clinical and Laboratory Standards Institute (CLSI). The results were interpreted according to the CLSI2013 M100-S23 guidelines [29]. The breakpoints of imipenem and meropenem for Enterobacteriaceae are as follows: susceptible (S), ≤1 µg/ml; resistant (R), ≥4 µg/ml, ertapenem S: ≤0.5 µg/ml, R: ≥2 µg/ml, aztreonam S: ≤4 µg/ml; R:≥16 µg/ml. Likewise, the breakpoints of imipenem and meropenem for the ABCs are: S:≤4 µg/ml; R:≥16 µg/ml. Tigecycline was interpreted according to the USA-FDA breakpoint (S: ≤2 µg/ml, R: ≥8 µg/ml).

PFGE

Bacterial DNA was prepared in agarose blocks and digested with restriction enzyme XbaI (four K. pneumonia species and Salmonella serotype Braenderup strainH9812) and ApaI (two A. calcoaceticus species). The DNA fragments were separated by use of a CHEF-Mapper XA PFGE system (Bio-Rad, Richmond, USA) at 6 V/cm and 14°, with a pulse angle of 120°, for 23 h and a switch time from 4 to 40 s for Enterobacteriaceae while 24 h and a switch time from 5 to 20 s for A. calcoaceticus. The gel was stained with ethidium bromide.

S1-PFGE and Southern blot hybridization

According to literature [30], bacterial DNA was prepared in agarose blocks and digested with S1 nuclease, and then separated by PFGE with conditions of 14 h at 6 V/cm and 14°, with a pulse angle of 120° and a switch time from 1 to 10 s. The gel was stained with ethidium bromide. The DNA fragments were transferred to nylon membranes (Hybond N, Amersham, UK), hybridized with digoxigenin-labeled blaNDM-1-specific probes and detected using an NBT/BCIP color detection kit (Roche, Basel, Switzerland).

Plasmid analysis and Southern blot hybridization

Plasmids were extracted by the SDS alkaline lysis method and then digested with EcoRI. The plasmid DNA fragments were separated by agarose gel electrophoresis at 90 v for 2 h. The gel was stained with ethidium bromide. The plasmid fragments were then transferred to a nylon membrane, hybridized with digoxigenin-labeled blaNDM-1-specific probes and detected using an NBT/BCIP color detection kit as above.

Conjugation experiments

Liquid mating was performed for the seven (using only one strain of M194 from the same clone represented by M186, M187, M194) NDM-1-producing strains, using E. coli J53 (azide resistant) as the recipient strain, with selection on Mueller-Hinton Agar containing sodium azide and ceftazidime: sodium azide 200 µg/ml and ceftazidime 16 µg/ml for U091, Q297, X122, G113, X231; and sodium azide 300 µg/ml and ceftazidime 16 µg/ml for M194, Q442 according to pre-experiments. When liquid mating failed, filter mating was then conducted to further test their transmission. The donor and recipient strains were added at a proportion of 1∶10 for both liquid mating and filter mating. Transconjugants were confirmed by PCR, and by API 20E and antimicrobial susceptibility testing.

Results

The identification of blaNDM-1-positive bacteria

PCR identified nine blaNDM-1-positive strains. The sequencing results of the amplicons showed all were 100% identical to K. pneumoniae strain 05–506 (GenBank accession number: FN396876). Three of them were from Hunan Province, two from Shaanxi Province, two from Zhejiang Province, one from Xinjiang Province and one from Jiangsu Province (Table 1), located in the East and Northwest of China. 16S rRNA sequencing and biochemical API strips revealed that four were K. pneumoniae (M186, M187, M194, U091), two were ABCs (G113, X231), one was Enterobacter cloacae (Q297), one was Enterobacter aerogenes (Q442) and one was Citrobacter freundii (X122), respectively. blaOXA-51-like detection in the two ABCs was negative, indicating that both G113 and X231 were A. calcoaceticus.

thumbnail
Table 1. Epidemiological characteristics of nine blaNDM-1-positive bacteria.

https://doi.org/10.1371/journal.pone.0113852.t001

The MICs of blaNDM-1-positive bacteria

All nine strains were highly resistant to a broad spectrum of antibiotics, including piperacillin, Third- and Fourth-cephalosporins, β-lactamase inhibitor combinations, most carbapenems and nitrofurantoin; however, they showed varied susceptibilities to aminoglycosides and tetracyclines. Fortunately, most strains showed susceptibility to fluoroquinolones and tigecycline (Table 2).

The transconjugants J53-U091, J53-Q297, J53-Q442 and J53-X122 were resistant to many antibiotics, including piperacillin, cephalosporins, β-lactamase inhibitor combinations and most tested carbapenems, but remained susceptible to tigecycline, ciprofloxacin, levofloxacin and polymyxin B. J53-G113 and J53-X231 did nor seem to be resistant to carbapenems; however, the MICs of the carbapenems were relatively high compared with those for the recipient E. coli J53 (Table 2).

PFGE

Three K. pneumoniae from the same hospital (M186, M187, M194) had the same PFGE profiles, indicating they were the same clone, while K. pneumoniae U091 showed a different profile, suggesting U091 was another clone (Figure 1A). Two A. calcoaceticus (G113, X231) showed different profiles (Figure 1B).

thumbnail
Figure 1. PFGE profiles of Salmonella serotype Braenderup strain (H9812), and four K. pneumoniae and two A. calcoaceticus isolates.

(A) PFGE profiles of H9812 and four K. pneumoniae isolates. Lane 1: Salmonella serotype Braenderup strain (H9812), as the marker. Lane 2∼5: four K. pneumoniae isolates (M186, M187, M194, U091, respectively). (B) PFGE profiles of H9812 and two A. calcoaceticus isolates. Lane 1: Salmonella serotype Braenderup strain (H9812), as the marker. Lane 2∼3: two A. calcoaceticus isolates, G113 and X231, respectively.

https://doi.org/10.1371/journal.pone.0113852.g001

S1-PFGE and Southern blot hybridization

From the hybridization results, we observed that seven strains (M186, M187, M194, Q297, Q442, G113 and X231) carried the blaNDM-1 gene on plasmids, whose sizes ranged from approx. 23 to approx. 80 kb. The blaNDM-1 gene in K. pneumoniae U091 was demonstrated as chromosomal. X122 failed to produce a blaNDM-1–specific fragment (Figure 2A, 2B).

thumbnail
Figure 2. Result of S1-PFGE and Southern blot hybridization.

(A) The left dark background figure shows the results of S1-PFGE, while the right light background shows the Southern blot hybridization. M: Low Range PFG Marker. Lane 1∼6: A. calcoaceticus G113, K. pneumoniae M186, K. pneumoniae M187, K. pneumoniae M194, K. pneumoniae U091 and Citrobacter freundii X122, respectively. (B) The left dark background figure shows the results of S1-PFGE, while the right light background shows the Southern blot hybridization. M: Low Range PFG Marker. Lane 1∼3: Enterobacter cloacae Q297, Enterobacter aerogenes Q442 and A. calcoaceticus X231, respectively.

https://doi.org/10.1371/journal.pone.0113852.g002

Plasmid analysis and Southern blot hybridization

Plasmid extraction and Southern blotting was performed to further check the location of the blaNDM-1 gene in the studied strains. K. pneumoniae U091 did not have any reactive bands (Figure 3A), suggesting that U091 does not have any plasmids. This was consistent with chromosomal location of the blaNDM-1 gene inferred from the S1-PFGE and Southern blot results. The other six strains all had plasmids and the sizes of plasmids were consistent with S1-PFGE results shown in Fig. 2. All plasmid DNAs were digested with restriction enzyme EcoRI restriction enzyme, whose recognition site (5′ G∧AATTC 3′) does not occur in the sequence of the blaNDM-1 gene, as far as we know. Therefore, EcoRI should not cleave the blaNDM-1 gene. Figure 3B shows an approximately 2KB band in all positive isolates that corresponds to the blaNDM-1 gene plus flanking plasmid sequences. We concluded that the blaNDM-1 gene was located on the plasmids of the six strains that harbored plasmids.

thumbnail
Figure 3. EcoRI-digestion profiles and Southern blotting results of extracted plasmids.

(A) Plasmid digested with EcoRI and then run in gel. (B) Southern blot hybridization results of digested plasmid DNA. M: λDNA\HindIII. Lane 1∼7: K. pneumoniae M194, Enterobacter cloacae Q297, Enterobacter aerogenes Q442, Citrobacter freundii X122, A. calcoaceticus G113, A. calcoaceticus X231 and K. pneumoniae U091, respectively.

https://doi.org/10.1371/journal.pone.0113852.g003

Conjugation experiments

Except for M194, the plasmids carrying blaNDM-1 from six strains were successfully transferred to E. coli J53. PCR confirmed the presence of the blaNDM-1 gene in the transconjugants and API 20E test confirmed them as E. coli. The MIC results are shown in Table 2. The plasmids of Q297, X122, G113 and X231 were transferred to E. coli J53 successfully by liquid mating, indicating that the blaNDM-1 gene from these strains can be disseminated easily, since liquid mating requires the strongest transfer ability among the three major conjugation methods: liquid mating, solid mating and filter mating. U091 and Q442 were conjugative by filter mating, while M194 failed.

Discussion

In the past few decades, an alarming increase in the prevalence of antimicrobial resistant pathogens causing serious community- and hospital-acquired infections has occurred worldwide. The increase in carbapenem resistance in Gram-negative bacteria has become a major concern. Bacteria producing NDM-1 have caused a global panic because they can hydrolyze almost all known β-lactam antimicrobials (except aztreonam), including the last resort carbapenems [3], and are referred to as “superbugs” by the media. To further complicate matters, the blaNDM-1 gene (encoding NDM-1) has disseminated rapidly over distantly-related geographical areas around the world [11], [15], [19], [20]. In terms of human hosts, there are three major routes to acquire an NDM-1 producing organism: nosocomial, personal travel and community acquisition. The blaNDM-1-carrying bacteria have been reported as gut colonizers in humans with or without clinical symptoms. They can also survive in the local environment, which may result in humans acquiring the blaNDM-1-positive bacteria unconsciously [5]. Hence, bacteria possessing the blaNDM-1 gene constitute a serious human health threat.

The most common mechanism of resistance to carbapenem is the production of carbapenemases (one of β-lactamases), including enzymes of Ambler class A, D and B (MBLs). NDM-1 is an MBL that mediates carbapenem-resistance. In this study, we confirmed that none of the blaNDM-1-bearing strains were susceptible to carbapenem.

The Chinese CDC has reported blaNDM-1-producing bacteria since 2010. Since then, there have been many studies on this issue. Chen et al. reported four A. baumannii on mainland China [2], Ho et al. reported one E. coli in Hong Kong [18] and Wu et al. reported K. pneumoniae in Tai Wan [21]. To date, a number of blaNDM-1-positive bacteria have been reported in China, and the species has included E. coli, K. pneumoniae, K. oxytoca, K. ozaenae, E. cloacae, E. aerogen, C. freundii, Salmonella enteritidis, Morganella morganii, Providencia spp., Alcaligenes faecalis, Kocuria varians, Moraxella group, Comamonas testosteroni, Stenotrophomonas maltophilia, Staphylococcus capitis, Methylobacterium species, Raoultella ornithinolytica, Acinetobacter spp. and E. faecium. Although there have been several molecular level researches on the genetic context of blaNDM-1, there are limited recent studies on the epidemiology of blaNDM-1-containing isolates [1], [2], [9], [13], [16], [23]. Compared with previous reports [2], [13], the present study demonstrated that the numbers and species of blaNDM-1 in family Enterobacteriaceae have significantly increased in China, and include Klebsiella pneumoniae, Enterobacter cloacae, Enterobacter aerogen and Citrobacter freundii. This is worrying because Enterobacteriaceae are the main cause of nosocomial infections.

Our study reported nine blaNDM-1-producing strains, of which three were the same clone. Except the K. pneumoniae U091, whose blaNDM-1 gene is chromosomal, Southern blotting showed that the blaNDM-1 genes were carried on plasmid in the other strains, which may permit them to transfer the gene to other strains and species, resulting in rapid horizontal transmission. Thus, we conducted conjugation experiments to further determine their transmission. The transconjugants J53-U091, J53-Q297, J53-Q442 and J53-X122 were resistant to almost all β-lactams, even aztreonam (Table 2), which is stable to MBLs, including NDM-1. This may be explained if more than one plasmid was transferred into E. coli J53 or the transferred element contained not only blaNDM-1 gene, but also other resistance determinants. Q297, X122, G113 and X231 may disseminate easily, because they were conjugative by liquid mating, which requires the strongest transfer ability among three major conjugation methods: liquid mating, solid mating and filter mating. This result should attract much attention. Interestingly, S1-PFGE, Southern blotting and plasmid extraction showed that U091 has no plasmids, yet the conjugation experiment was successful. It may be that its blaNDM-1 gene is carried on a transposon in the chromosome, which requires further study. Sequencing of the blaNDM-1 harboring plasmids or the flanking regions of the gene is required to better understand the genetic environment and transmission of this important multidrug resistance gene.

Acknowledgments

We thank the following participants and member hospitals of Mohnarin surveillance program (The names are arranged without priority):

Yunjian Hu (Beijing Hospital, Beijing, 100730), Ting Yu (The Second Hospital of Jilin University, Changchun, 130041), Zhidong Hu (Tianjin Medical University General Hospital, Tianjin, 300052), Jianhong Zhao(The Second Hospital of Hebei Medical University, Shijiazhuang, 050000), Shiyang Pan (The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029), Bijie Hu (Zhongshan Hospital Fudan University, Shanghai, 200023), Yunsong Yu (Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003), Qiulian Deng (Guangzhou Women and Children’s Medical Center, Guangzhou, 510623), Yan Li (Renmin Hospital of Wuhan University, Wuhan, 430060), Wenen Liu (Xiangya Hospital Central South University, Changsha, 410008), Ling Zhou (The First People’s Hospital of Kunming, Kunming, 650011), Ying Fei (Affiliated Hospital of Guiyang Medical College, Guiyang, 550001), Wei Fu (The Third Military Medical University Southwest Hospital, Chongqing, 400038), Xiuli Xu (The Fourth Military Medical University Xijing Hospital, Xi’an, 710032), Fengyan Pei (Jinan Central Hospital Affiliated to Shandong University, Jinan, 250013), Ling Meng (Lanzhou University Second Hospital, Lanzhou, 730030), Ping Ji (The First Teaching Hospital of Xinjiang Medical University, Urumchi, 830054), Jin Tang (Hanzhong Central Hospital, Hanzhong, 723000).

Author Contributions

Conceived and designed the experiments: WO Y. Lv. Performed the experiments: WO. Analyzed the data: WO LC Y. Li BZ Y. Lv. Contributed reagents/materials/analysis tools: Y. Li Y. Lv. Wrote the paper: WO LC Y. Lv.

References

  1. 1. Liu Z, Li W, Wang J, Pan J, Sun S, et al. (2013) Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China. PLoS One 8:e66666.
  2. 2. Chen Y, Zhou Z, Jiang Y, Yu Y (2011) Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother 66:1255–1259.
  3. 3. Dortet L, Poirel L, Nordmann P (2014) Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int 2014:1–12.
  4. 4. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, et al. (2009) Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054.
  5. 5. Wailan AM, Paterson DL (2014) The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev Anti Infect Ther 12:91–115.
  6. 6. Wang SJ, Chiu SH, Lin YC, Tsai YC, Mu JJ (2013) Carbapenem resistant Enterobacteriaceae carrying New Delhi metallo-beta-lactamase gene (NDM-1) in Taiwan. Diagn Microbiol Infect Dis 76:248–249.
  7. 7. Zhou G, Guo S, Luo Y, Ye L, Song Y, et al. (2014) NDM-1-producing Strains, Family Enterobacteriaceae, in Hospital, Beijing, China. Emerg Infect Dis 20:340–342.
  8. 8. Du XX, Wang JF, Fu Y, Zhao F, Chen Y, et al. (2013) Genetic characteristics of blaNDM-1-positive plasmid in Citrobacter freundii isolate separated from a clinical infectious patient. J Med Microbiol 62:1332–1337.
  9. 9. Zhou WQ, Zhang ZF, Shen H, Ning MZ, Xu XJ, et al. (2013) First report of the emergence of New Delhi metallo-beta-lactamase-1 producing Acinetobacter junii in Nanjing, China. Indian J Med Microbiol 31:206–207.
  10. 10. Decousser JW, Jansen C, Nordmann P, Emirian A, Bonnin RA, et al. (2013) Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill 18:1–4.
  11. 11. Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, et al. (2012) Dissemination of New Delhi metallo-beta-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect 18:E362–E365.
  12. 12. Karthikeyan K, Thirunarayan MA, Krishnan P (2010) Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 65:2253–2254.
  13. 13. Ho PL, Li Z, Lai EL, Chiu SS, Cheng VC (2012) Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother 67:1553–1555.
  14. 14. Chen Z, Qlu S, Wang Y, Wang Y, Liu S, et al. (2011) Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin Infect Dis 52:692–693.
  15. 15. United States (2010) Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase. MMWR Morb Mortal Wkly Rep 59:750.
  16. 16. Fu Y, Du X, Ji J, Chen Y, Jiang Y, et al. (2012) Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China. J Antimicrob Chemother 67:2114–2122.
  17. 17. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Gottig S, et al. (2011) Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother 66:1998–2001.
  18. 18. Ho PL, Lo WU, Yeung MK, Lin CH, Chow KH, et al. (2011) Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One 6:e17989.
  19. 19. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602.
  20. 20. Sole M, Pitart C, Roca I, Fabrega A, Salvador P, et al. (2011) First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother 55:4402–4404.
  21. 21. Wu HS, Chen TL, Chen IC, Huang MS, Wang FD, et al. (2010) First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. J Chin Med Assoc 73:596–598.
  22. 22. Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P (2010) Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis 10:832.
  23. 23. Wang Y, Wu C, Zhang Q, Qi J, Liu H, et al. (2012) Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One 7:e37152.
  24. 24. Boulanger A, Naas T, Fortineau N, Figueiredo S, Nordmann P (2012) NDM-1-producing Acinetobacter baumannii from Algeria. Antimicrob Agents Chemother 56:2214–2215.
  25. 25. Poirel L, Dortet L, Bernabeu S, Nordmann P (2011) Genetic Features of blaNDM-1-Positive Enterobacteriaceae. Antimicrob Agents Chemother 55:5403–5407.
  26. 26. Yin JW, Xu W, Gu WP, Zhou YM, Li CQ, et al. 2012) Detection of a strain of Klebsiella oxytoca carrying blaNDM-1 in Yunnan province. Disease Surveillance 27:211–217.
  27. 27. Kim TW, Kim YH, Kim SE, Lee JH, Park CS, et al. (2010) Identification and distribution of Bacillus species in doenjang by whole-cell protein patterns and 16S rRNA gene sequence analysis. J Microbiol Biotechnol 20:1210–1214.
  28. 28. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, et al. (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353.
  29. 29. Clinical and Laboratory Standards Institute (2013) Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23. CLSI, Wayne, PA.
  30. 30. Barton BM, Harding GP, Zuccarelli AJ (1995) A general method for detecting and sizing large plasmids. Anal Biochem 226:235–240.